Login / Signup
High dose carfilzomib proteasome inhibition induces anemia by oxidative hemolysis: A case series of 8 patients from a single centre.
Rajeev Rajagopal
Rory Bennett
James Liang
Gordon Royle
Published in:
American journal of hematology (2019)
Keyphrases
</>
high dose
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
low dose
prognostic factors
peritoneal dialysis
patient reported outcomes